Login
REGENERON PHARMACEUTICALS, INC. logo

REGENERON PHARMACEUTICALS, INC.

Compare classes
regeneron.com

What Do They Do?

Develops, manufactures, and sells medicines for people with serious diseases.

How Do They Make Money?

Most revenue comes from collaborations (51%): partners share product profits, reimburse research and manufacturing costs, and pay royalties or sales milestones. Regeneron also sells medicines, with revenue tied to customer receipt or acceptance.

FY2025 revenue by product or service revenue
SegmentShareRevenue
Net product sales
Sold outright

44%
FY2022: 57%
Collaboration revenue
51%
FY2022: 40%
Other revenue
4.9%
FY2022: 3.0%

Who Are Their Customers?

Product customers include distributors and specialty pharmacies, and the company also sells at discounted prices to qualified healthcare providers. Collaborators work with Regeneron on research, development, manufacturing, and commercialization.

Do Revenues Turn Into Profits?

Yes. It kept 31 cents of every revenue dollar as net income in FY2025 and turned 28 cents into free cash flow.

Operating income, FY2025
25% of revenue
▼ −10% vs FY2024 ($4B, 28%)
Net income, FY2025
31% of revenue
▲ +2% vs FY2024 ($4.4B, 31%)
Free cash flow, FY2025
28% of revenue
▲ +11% vs FY2024 ($3.7B, 26%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +36%
vs $3.8B in Q3 FY2025
Net income
▲ +33%
vs $1.5B in Q3 FY2025
Collaboration revenue share of revenue vs 52.4% in Q3 FY2025

Shrinking. Revenue fell 11% in 4 years, from $16.1B in FY2021 to $14.3B in FY2025, about 3% a year.

Revenue over time
Net product sales Collaboration revenue Other revenue
$20B$10B$0

Who Do They Compete With?

Competes with Outlook Therapeutics, Novartis, AbbVie, Alimera Sciences, Amgen, Sandoz, Sam Chun Dang, Samsung Bioepis, Harrow, Xbrane Biopharma, STADA Arzneimittel, Formycon, Bioeq, Teva, Zydus Lifesciences, Almirall, Eli Lilly, Pfizer, AstraZeneca, and GSK

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support